Back to Search
Start Over
Efficacy of percutaneous radiofrequency ablation for hepatocellular carcinoma treatment in patients aged ≥80 years
- Source :
- Liver Research, Vol 4, Iss 4, Pp 206-211 (2020)
- Publication Year :
- 2020
- Publisher :
- KeAi Communications Co., Ltd., 2020.
-
Abstract
- Background: Although radiofrequency ablation (RFA) is a minimally invasive treatment for early-stage hepatocellular carcinoma (HCC), it remains unclear whether RFA achieves favorable outcomes in patients aged ≥80 years. This study aimed to determine the efficacy and safety of RFA for HCC in patients aged ≥80 years. Methods: A total of 512 naïve patients with HCC who had undergone RFA from January 2001 to December 2016 were enrolled. They were categorized into the ≥80-year-old group and the control group (aged
Details
- Language :
- English
- ISSN :
- 25425684
- Volume :
- 4
- Issue :
- 4
- Database :
- Directory of Open Access Journals
- Journal :
- Liver Research
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.2651384fca04552847544a0d2e3687e
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/j.livres.2020.11.005